Skip to contents

DIVINE's vaccine table

Source: R/vaccine.R
vaccine.Rd

Information on COVID-19 vaccines of patients included in the DIVINE cohort. Data was collected at hospital admission and it is available for waves 3 and 5 (patients were not yet vaccinated in waves 1 and 2).

Usage

data(vaccine)

Format

A data frame with 5813 rows and 6 columns

record_id:

Identifier of each record. This information does not match the real data.

covid_wave:

A factor with levels Wave 1, Wave 2, Wave 3, and Wave 5. COVID-19 wave.

center:

A factor with levels Hospital A, Hospital B, Hospital C, Hospital D, and Hospital E. Center of admission

vaccine:

A factor with levels No, Yes and Not applicable (for patients included in waves before vaccination started). Is the patient vaccinated for COVID-19?

complete_vaccine:

A factor with levels No, Partial, Complete and Not applicable (for patients included in waves before vaccination started). Is the patient partially vaccinated (one dose of two-dose vaccines), completely vaccinated (one dose for one-dose vaccines or two doses for two-dose vaccines) or not vaccinated at all?

immune_vaccine:

A factor with levels No immunity, Partial immunity, Total immunity and Not applicable (for patients included in waves before vaccination started). Defines the level of immunity of the patient: not vaccinated (No immunity), vaccinated with only one dose for two-dose vaccines (Partial immunity), vaccinated with two doses but less than 7 days have passed since the second dose (Partial immunity) or vaccinated with all the doses and more than 7 days have passed since the second dose (Total immunity)

References

Pallarès, N., Tebé, C., Abelenda-Alonso, G., Rombauts, A., Oriol, I., Simonetti, A. F., Rodríguez-Molinero, A., Izquierdo, E., Díaz-Brito, V., Molist, G., Gómez Melis, G., Carratalà, J., Videla, S., & MetroSud and Divine study groups (2023). Characteristics and Outcomes by Ceiling of Care of Subjects Hospitalized with COVID-19 During Four Waves of the Pandemic in a Metropolitan Area: A Multicenter Cohort Study. Infectious diseases and therapy, 12(1), 273–289. https://doi.org/10.1007/s40121-022-00705-w